Lessons from Pharmacovigilance: Pulmonary Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.
Lung
; 199(2): 199-211, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33616727
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immune Checkpoint Inhibitors
/
Lung Diseases
Type of study:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Lung
Year:
2021
Type:
Article
Affiliation country:
United States